Evolution of chemical-specific adjustment factors (CSAF) based on recent international experience; increasing utility and facilitating regulatory acceptance-Reference-Cited by-同舟云学术

Evolution of chemical-specific adjustment factors (CSAF) based on recent international experience; increasing utility and facilitating regulatory acceptance

Published:2017-07-06 Issue:9 Volume:47 Page:733-753
ISSN:1040-8444
Container-title:Critical Reviews in Toxicology
language:en
Short-container-title:Critical Reviews in Toxicology

Author:

Bhat Virunya S.¹,Meek M.E. (Bette)²,Valcke Mathieu³⁴,English Caroline¹,Boobis Alan⁵,Brown Richard⁶

Affiliation:

1. WHO Collaborating Centre on Water and Indoor Air Quality and Food Safety, NSF International, Ann Arbor, MI, USA;

2. McLaughlin Centre for Population Health Risk Assessment, University of Ottawa, Ontario, Canada;

3. Toxicological and Radiological Risk Assessment Group, Institut National de Santé Publique du Québec (INSPQ), Montreal, Canada;

4. Department of Environmental and Occupational Health, École de Santé Publique, Université de Montréal (ESPUM), Québec, Canada;

5. Department of Medicine, Imperial College, London, UK;

6. International Programme on Chemical Safety, World Health Organization, Geneva, Switzerland

Publisher

Informa UK Limited

Subject

Toxicology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10408444.2017.1303818

Reference104 articles.

1. Characterizing Uncertainty and Variability in Physiologically Based Pharmacokinetic Models: State of the Science and Needs for Research and Implementation

2. Increasing Scientific Confidence in Adverse Outcome Pathways: Application of Tailored Bradford-Hill Considerations for Evaluating Weight of Evidence

3. Toxicity Testing in the 21st Century: Defining New Risk Assessment Approaches Based on Perturbation of Intracellular Toxicity Pathways

4. Codex Alimentarius Commission. 2013. Codex Alimentarius Commission Procedural Manual. Twenty-first edition. World Health Organization, Food and Agriculture Organization of the United Nations. Rome, 2013. Available from: http://www.fao.org/3/a-i3243e.pdf

5. Evaluation of the Potential Impact of Age- and Gender-Specific Pharmacokinetic Differences on Tissue Dosimetry 2Current address: Novartis Pharmaceuticals, East Hanover, NJ 07936.

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Haloacetamides disinfection by-products, a potential risk factor for nonalcoholic fatty liver disease;Water Research;2024-09

2. Data derived extrapolation factors (DDEFs) for rat to human interspecies extrapolation for the HPPD inhibitor mesotrione;Critical Reviews in Toxicology;2024-06-13

3. Mixed exposure to haloacetaldehyde disinfection by-products exacerbates lipid aggregation in the liver of mice;Environmental Pollution;2024-06

4. Development and application of the physiologically-based toxicokinetic (PBTK) model for ochratoxin A (OTA) in rats and humans;Ecotoxicology and Environmental Safety;2024-05

5. Development of a population attributable risk screening tool to estimate health consequences of consumer product exposure;Environment Systems and Decisions;2024-04-12